Fundraising Fox
Zentalis
123 employees on LinkedIn · 2 known investors
Find your way into Zentalis
Each arrow is one introduction. Sign up to fill in the first one.
151 people can intro you to Julie
Ask Cam Gallagher to introduce you to Julie Eastland
You →Cam · together at Zentalis →Julie
Sign up to find every way you can get introduced to Zentalis
- Your email: who you already know at Zentalis, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Zentalis team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Zentalis is a biopharmaceutical company developing azenosertib and other pipeline assets, seeking strategic partnerships to advance drug development and expand market reach globally.
Founders & leadership
JE
Julie EastlandChief Executive Officer and DirectorJulie Eastland is Chief Executive Officer and Director of Zentalis, a biopharmaceutical company developing azenosertib and other pipeline assets. With over 25 years of experience in life sciences, she has previously served as CEO of Harpoon Therapeutics through its acquisition by Merck for $680 million and brings deep financial and commercial expertise to drug development and company scaling.
Board
SM
Scott MyersChairperson
Investors · 2
Founder mafia
2 people who came through Zentalis went on to found or lead other companies.
In the news
Frequently asked questions
- What does Zentalis do?
- Zentalis is a biopharmaceutical company developing azenosertib and other pipeline assets, seeking strategic partnerships to advance drug development and expand market reach globally.
- Who are Zentalis's investors?
- Zentalis's investors include Decheng Capital, Highlight Capital.